Trending...
- K Spa in Bellevue Now Accepts HSA and FSA for Medically Necessary Massage Therapy
- Spokane: Mayor Brown Announces Proposals to Jumpstart New Affordable Housing Developement
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
SEATTLE and TOKYO, April 8, 2021 /PRNewswire/ -- Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Japan, announced today the final closing of its second fund, Remiges BioPharma Fund II raising a total of $95 million by welcoming new and returning investors, including Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan), 1Globe Capital, LLC (Boston, MA), EA Pharma Co., Ltd. (Tokyo, Japan) and Senju Pharmaceutical Co., Ltd. (Osaka, Japan).
Remiges is also delighted to announce the launch of RDiscovery, a new life sciences incubator to nurture and advance early-stage therapeutic concepts and technologies with the goal of bringing them to a more mature stage of development. RDiscovery will operate as a wholly owned subsidiary of Remiges Ventures, allowing for an efficient and seamless transition of projects from pre-seed, early development to a stage where company formation and investment syndication makes sense. RDiscovery will serve as an integrated innovation engine extending the capacity and capabilities of Remiges Ventures to execute on its strategy of harnessing novel science from Japanese academia and launching it on a patient-centered and commercially-focused path.
More on Washingtoner
"We are extremely pleased to close our second fund with six major healthcare companies both in the US and Japan and establish RDiscovery a new life science incubator," commented Taro Inaba, Founder and Managing Partner of Remiges Ventures. "The team is delighted to be working under our unique cross-border strategy to build new companies based on innovative seed technologies invented by researchers at Japanese academia and investing in early-stage companies globally."
About Remiges Ventures
Remiges Ventures focuses on company creation and investments in early-stage drug discovery and development companies. With its team located in the US and Japan, Remiges Ventures understands the drug discovery and biotech environments in both regions and marries the entrepreneurship and biotech ecosystem in the US with Japan's rich life science innovation. Additionally, with a limited partner base that includes Japanese and US healthcare companies, Remiges Ventures possesses a unique vantage point from which it creates and mines opportunities.
CONTACT:
Walter Olesiak
[email protected]
SOURCE Remiges Ventures, Inc.
Remiges is also delighted to announce the launch of RDiscovery, a new life sciences incubator to nurture and advance early-stage therapeutic concepts and technologies with the goal of bringing them to a more mature stage of development. RDiscovery will operate as a wholly owned subsidiary of Remiges Ventures, allowing for an efficient and seamless transition of projects from pre-seed, early development to a stage where company formation and investment syndication makes sense. RDiscovery will serve as an integrated innovation engine extending the capacity and capabilities of Remiges Ventures to execute on its strategy of harnessing novel science from Japanese academia and launching it on a patient-centered and commercially-focused path.
More on Washingtoner
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Spokane: National Night Out Against Crime is August 5th
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
"We are extremely pleased to close our second fund with six major healthcare companies both in the US and Japan and establish RDiscovery a new life science incubator," commented Taro Inaba, Founder and Managing Partner of Remiges Ventures. "The team is delighted to be working under our unique cross-border strategy to build new companies based on innovative seed technologies invented by researchers at Japanese academia and investing in early-stage companies globally."
About Remiges Ventures
Remiges Ventures focuses on company creation and investments in early-stage drug discovery and development companies. With its team located in the US and Japan, Remiges Ventures understands the drug discovery and biotech environments in both regions and marries the entrepreneurship and biotech ecosystem in the US with Japan's rich life science innovation. Additionally, with a limited partner base that includes Japanese and US healthcare companies, Remiges Ventures possesses a unique vantage point from which it creates and mines opportunities.
CONTACT:
Walter Olesiak
[email protected]
SOURCE Remiges Ventures, Inc.
Filed Under: Business
0 Comments
Latest on Washingtoner
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
- Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft
- Spokane Firefighters Battle 15 Suspicious Fires in 36 Hours
- Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- Alaska Air Group announces webcast of second-quarter 2025 financial results
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
- Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
- Miami Real Estate Agent Drastically Increases Interest In Homes
- Adostics & Genmega Announce the Introduction of A-POD
- Erie Home Celebrates 100th Location, Cementing Coast-to-Coast Footprint
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Spokane: SPD Investigates Several Intentionally Set Fires
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- City of Spokane Announces New Deputy Police Ombuds
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros